doi: 10.1111/j.1600-0609.2004.00395.x.
Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3
- PMID: 15777350
- DOI: 10.1111/j.1600-0609.2004.00395.x
Item in Clipboard
Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3
Eur J Haematol.
2005 Apr.
No abstract available
Similar articles
-
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease.Calcif Tissue Int. 2004 Jan;74(1):103-6. doi: 10.1007/s00223-003-0011-y. Epub 2003 Oct 6. Calcif Tissue Int. 2004. PMID: 14523602 Review.
-
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification.Thromb Haemost. 2005 Dec;94(6):1335-7. doi: 10.1160/TH05-06-1335. Thromb Haemost. 2005. PMID: 16411417 No abstract available.
-
Osteoclast differentiation and activation.Nature. 2003 May 15;423(6937):337-42. doi: 10.1038/nature01658. Nature. 2003. PMID: 12748652 Review.
-
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.Clin Transplant. 2006 May-Jun;20(3):383-8. doi: 10.1111/j.1399-0012.2006.00497.x. Clin Transplant. 2006. PMID: 16824158
-
RANK ligand and osteoprotegerin: emerging roles in mucosal inflammation.Gut. 2005 Sep;54(9):1345-6. doi: 10.1136/gut.2005.070623. Gut. 2005. PMID: 16099805 Free PMC article. No abstract available.
Cited by
-
Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies.Int J Mol Sci. 2024 Mar 1;25(5):2902. doi: 10.3390/ijms25052902. Int J Mol Sci. 2024. PMID: 38474150 Free PMC article. Review.
-
Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss.PLoS One. 2016 Feb 1;11(2):e0148292. doi: 10.1371/journal.pone.0148292. eCollection 2016. PLoS One. 2016. PMID: 26829642 Free PMC article.
-
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12. Haematologica. 2014. PMID: 25216685 Free PMC article.
-
Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.Blood Adv. 2018 Nov 13;2(21):2837-2847. doi: 10.1182/bloodadvances.2018023085. Blood Adv. 2018. PMID: 30381400 Free PMC article. Clinical Trial.
-
Does Microwave Exposure at Different Doses in the Pre/Postnatal Period Affect Growing Rat Bone Development?Physiol Res. 2024 Mar 11;73(1):157-172. doi: 10.33549/physiolres.935148. Physiol Res. 2024. PMID: 38466013 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
